FindTrial
Sign In

Ultrasound-guided Hyaluronic acid injection in Trapeziometarcarpal joint arthritis: a triple blind, randomised clinical trial of efficacy and safety

efficacy and safety of Hyaluronic acid injection in Trapeziometarcarpal joint arthritis

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20201221005
Enrollment
60
Registered
2020-12-21
Start date
2021-03-01
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trapeziometarcarpal joint arthritis

Interventions

Ultrasound&#45
guided Hyaluronic acid injection in Trapeziometarcarpal joint arthritis ,Ultrasound&#45
guided normal saline injection in Trapeziometarcarpal joint arthritis
Experimental Drug,Placebo Comparator Drug
Hyaluronic acid injection in Trapeziometarcarpal joint arthritis, normal saline injection in Trapeziometarcarpal joint arthritis

Sponsors

lerdsin hospital
Lead Sponsor
lerdsin hospital
Collaborator

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: Trapeziometarcarpal joint arthritis Eaton stage 1-3

Exclusion criteria

Exclusion criteria: 1. history inflammation arthritis, infection 2. previous thumb base trauma 3. patient who coagulation disorder, treat anticoagulants,treat antiplatelet drugs 4. skin disease 5. known allergy eggs, feathers, avian, proteins or HA 6. pregnancy

Design outcomes

Primary

MeasureTime frame
pain score 4,12,24 weeks after injection Visual analog scale—

Secondary

MeasureTime frame
disabilities of the arm, shoulder, and hand 4,12,24 weeks after injection quickDASH score—

Countries

Thailand

Contacts

Public ContactWarissara Cheewachatchaval

Lerdsin Hospital

loneaming@gmail.com+66827940611

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026